{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:46:33Z","timestamp":1772538393089,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There is a demand for serum markers for the routine assessment of the progression of liver cancer. We previously found that serum N-linked sugar chains are altered in hepatocellular carcinoma (HCC). Here, we studied glycomic alterations during development of HCC in a rat model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Rat HCC was induced by the hepatocarcinogen, diethylnitrosamine (DENA). N-glycans were profiled using the DSA-FACE technique developed in our laboratory.<\/jats:p>\n            <jats:p>In comparison with control rats, DENA rats showed a gradual but significant increase in two glycans (R5a and R5b) in serum total N-glycans during progression of liver cirrhosis and cancer, and a decrease in a biantennary glycan (P5). The log of the ratio of R5a to P1 (NGA2F) and R5b to P1 [log(R5a\/P1) and log(R5b\/P1)] were significantly (p &lt; 0.0001) elevated in HCC rats, but not in rats with cirrhosis or fibrosis or in control rats. We thus propose a GlycoTest model using the above-mentioned serum glycan markers to monitor the progression of cirrhosis and HCC in the DENA-treated rat model. When DENA-treated rats were subsequently treated with farnesylthiosalicyclic acid, an anticancer drug, progression to HCC was prevented and GlycoTest markers (P5, R5a and R5b) reverted towards non-DENA levels, and the HCC-specific markers, log(R5a\/P1) and log(R5b\/P1), normalized completely. <jats:bold>Conclusions<\/jats:bold>: We found an increase in core-\u03b1-1,6-fucosylated glycoproteins in serum and liver of rats with HCC, which demonstrates that fucosylation is altered during progression of HCC. Our GlycoTest model can be used to monitor progression of HCC and to follow up treatment of liver tumors in the DENA rat. This GlycoTest model is particularly important because a rapid non-invasive diagnostic procedure for tumour progression in this rat model would greatly facilitate the search for anticancer drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-9-215","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T18:20:10Z","timestamp":1281637210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat"],"prefix":"10.1186","volume":"9","author":[{"given":"Meng","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylviane","family":"Dewaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"St\u00e4rkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Vanhooren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-mu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Horsmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Libert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiying Chitty","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001, 94: 153-156. 10.1002\/ijc.1440","journal-title":"Int J Cancer"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1097\/00004836-200211002-00002","volume":"35","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002, 35: S72-78. 10.1097\/00004836-200211002-00002","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 1","key":"730_CR3","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL: Liver fibrosis -- from bench to bedside. J Hepatol. 2003, 38 (Suppl 1): S38-53. 10.1016\/S0168-8278(02)00429-4","journal-title":"J Hepatol"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","volume":"36","author":"M Pinzani","year":"2004","unstructured":"Pinzani M, Rombouts K: Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004, 36: 231-242. 10.1016\/j.dld.2004.01.003","journal-title":"Dig Liver Dis"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0168-8278(03)00010-2","volume":"38","author":"WM Rosenberg","year":"2003","unstructured":"Rosenberg WM: Rating fibrosis progression in chronic liver diseases. J Hepatol. 2003, 38: 357-360. 10.1016\/S0168-8278(03)00010-2","journal-title":"J Hepatol"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1373\/clinchem.2004.035899","volume":"50","author":"NH Afdhal","year":"2004","unstructured":"Afdhal NH: Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis?. Clin Chem. 2004, 50: 1299-1300. 10.1373\/clinchem.2004.035899","journal-title":"Clin Chem"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1089-3261(05)70158-6","volume":"5","author":"PJ Johnson","year":"2001","unstructured":"Johnson PJ: The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis. 2001, 5: 145-159. 10.1016\/S1089-3261(05)70158-6","journal-title":"Clin Liver Dis"},{"key":"730_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1572-0241.2006.00467.x","volume":"101","author":"A Colli","year":"2006","unstructured":"Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, Duca P: Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006, 101: 513-523. 10.1111\/j.1572-0241.2006.00467.x","journal-title":"Am J Gastroenterol"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/bmc.167","volume":"16","author":"N Anderson","year":"2002","unstructured":"Anderson N, Pollacchi A, Hayes P, Therapondos G, Newsome P, Boyter A, Smith K: A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases. Biomed Chromatogr. 2002, 16: 365-372. 10.1002\/bmc.167","journal-title":"Biomed Chromatogr"},{"key":"730_CR10","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0021-9258(19)81629-0","volume":"264","author":"K Yamashita","year":"1989","unstructured":"Yamashita K, Koide N, Endo T, Iwaki Y, Kobata A: Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem. 1989, 264: 2415-2423.","journal-title":"J Biol Chem"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1021\/pr060664t","volume":"6","author":"Z Kyselova","year":"2007","unstructured":"Kyselova Z, Mechref Y, Al Bataineh MM, Dobrolecki LE, Hickey RJ, Vinson J, Sweeney CJ, Novotny MV: Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res. 2007, 6: 1822-1832. 10.1021\/pr060664t","journal-title":"J Proteome Res"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-3083.2000.00685.x","volume":"51","author":"C Basset","year":"2000","unstructured":"Basset C, Durand V, Jamin C, Clement J, Pennec Y, Youinou P, Dueymes M, Roitt IM: Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjogren's syndrome. Scand J Immunol. 2000, 51: 300-306. 10.1046\/j.1365-3083.2000.00685.x","journal-title":"Scand J Immunol"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1006","volume":"10","author":"N Callewaert","year":"2004","unstructured":"Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R: Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004, 10: 429-434. 10.1038\/nm1006","journal-title":"Nat Med"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1074\/mcp.M800470-MCP200","volume":"8","author":"D Vanderschaeghe","year":"2009","unstructured":"Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N: GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009, 8: 986-994. 10.1074\/mcp.M800470-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1478-3231.2009.02170.x","volume":"30","author":"HL Gui","year":"2010","unstructured":"Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C: Altered serum N-glycomics in chronic hepatitis B patients. Liver Int. 2010, 30: 259-267. 10.1111\/j.1478-3231.2009.02170.x","journal-title":"Liver Int"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.21855","volume":"46","author":"XE Liu","year":"2007","unstructured":"Liu XE, Desmyter L, Gao CF, Laroy W, Dewaele S, Vanhooren V, Wang L, Zhuang H, Callewaert N, Libert C: N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology. 2007, 46: 1426-1435. 10.1002\/hep.21855","journal-title":"Hepatology"},{"key":"730_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mad.2008.11.008","volume":"130","author":"V Vanhooren","year":"2009","unstructured":"Vanhooren V, Liu XE, Franceschi C, Gao CF, Libert C, Contreras R, Chen C: N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing. Mech Ageing Dev. 2009, 130: 92-97. 10.1016\/j.mad.2008.11.008","journal-title":"Mech Ageing Dev"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ijc.25030","volume":"127","author":"M Fang","year":"2010","unstructured":"Fang M, Zhao YP, Zhou FG, Lu LG, Qi P, Wang H, Zhou K, Sun SH, Chen CY, Gao CF: N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma. Int J Cancer. 2010, 127: 148-159.","journal-title":"Int J Cancer"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.20538","volume":"41","author":"E Schiffer","year":"2005","unstructured":"Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, Clergue F, Poupon R, Barbu V, Rosmorduc O: Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology. 2005, 41: 307-314. 10.1002\/hep.20538","journal-title":"Hepatology"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","volume":"48","author":"P Newell","year":"2008","unstructured":"Newell P, Villanueva A, Friedman SL, Koike K, Llovet JM: Experimental models of hepatocellular carcinoma. J Hepatol. 2008, 48: 858-879. 10.1016\/j.jhep.2008.01.008","journal-title":"J Hepatol"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00204-007-0273-7","volume":"82","author":"C Kohle","year":"2008","unstructured":"Kohle C, Schwarz M, Bock KW: Promotion of hepatocarcinogenesis in humans and animal models. Arch Toxicol. 2008, 82: 623-631. 10.1007\/s00204-007-0273-7","journal-title":"Arch Toxicol"},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/1535-7163.MCT-06-0706","volume":"6","author":"A Zundelevich","year":"2007","unstructured":"Zundelevich A, Elad-Sfadia G, Haklai R, Kloog Y: Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid). Mol Cancer Ther. 2007, 6: 1765-1773. 10.1158\/1535-7163.MCT-06-0706","journal-title":"Mol Cancer Ther"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.ejca.2009.04.014","volume":"45","author":"T Schneider-Merck","year":"2009","unstructured":"Schneider-Merck T, Borbath I, Charette N, De Saeger C, Abarca J, Leclercq I, Horsmans Y, Starkel P: The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats. Eur J Cancer. 2009, 45: 2050-2060. 10.1016\/j.ejca.2009.04.014","journal-title":"Eur J Cancer"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0300-9084(01)01294-9","volume":"83","author":"U Galili","year":"2001","unstructured":"Galili U: The alpha-gal epitope (Gal alpha 1-3Gal beta 1-4GlcNAc-R) in xenotransplantation. Biochimie. 2001, 83: 557-563. 10.1016\/S0300-9084(01)01294-9","journal-title":"Biochimie"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1440-1711.2005.01366.x","volume":"83","author":"U Galili","year":"2005","unstructured":"Galili U: The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol. 2005, 83: 674-686. 10.1111\/j.1440-1711.2005.01366.x","journal-title":"Immunol Cell Biol"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"15700","DOI":"10.1074\/jbc.M701195200","volume":"282","author":"K Matsumura","year":"2007","unstructured":"Matsumura K, Higashida K, Ishida H, Hata Y, Yamamoto K, Shigeta M, Mizuno-Horikawa Y, Wang X, Miyoshi E, Gu J, Taniguchi N: Carbohydrate binding specificity of a fucose-specific lectin from Aspergillus oryzae: a novel probe for core fucose. J Biol Chem. 2007, 282: 15700-15708. 10.1074\/jbc.M701195200","journal-title":"J Biol Chem"},{"key":"730_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/hep.1840170110","volume":"17","author":"Y Aoyagi","year":"1993","unstructured":"Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H: Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 1993, 17: 50-52. 10.1002\/hep.1840170110","journal-title":"Hepatology"},{"key":"730_CR28","first-page":"5419","volume":"53","author":"K Taketa","year":"1993","unstructured":"Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, Matsuura S, Kawai T, Hirai H: A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993, 53: 5419-5423.","journal-title":"Cancer Res"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-4615-1885-3_25","volume":"376","author":"GA Turner","year":"1995","unstructured":"Turner GA: Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv Exp Med Biol. 1995, 376: 231-238.","journal-title":"Adv Exp Med Biol"},{"key":"730_CR30","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1002\/ijc.21728","volume":"118","author":"N Okuyama","year":"2006","unstructured":"Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer. 2006, 118: 2803-2808. 10.1002\/ijc.21728","journal-title":"Int J Cancer"},{"key":"730_CR31","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1074\/jbc.272.5.2866","volume":"272","author":"AS Sultan","year":"1997","unstructured":"Sultan AS, Miyoshi E, Ihara Y, Nishikawa A, Tsukada Y, Taniguchi N: Bisecting GlcNAc structures act as negative sorting signals for cell surface glycoproteins in forskolin-treated rat hepatoma cells. J Biol Chem. 1997, 272: 2866-2872. 10.1074\/jbc.272.5.2866","journal-title":"J Biol Chem"},{"key":"730_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/jb\/mvn011","volume":"143","author":"E Miyoshi","year":"2008","unstructured":"Miyoshi E, Moriwaki K, Nakagawa T: Biological function of fucosylation in cancer biology. J Biochem. 2008, 143: 725-729. 10.1093\/jb\/mvn011","journal-title":"J Biochem"},{"key":"730_CR33","first-page":"43","volume":"96","author":"RA Dwek","year":"1998","unstructured":"Dwek RA: Biological importance of glycosylation. Dev Biol Stand. 1998, 96: 43-47.","journal-title":"Dev Biol Stand"},{"key":"730_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ymeth.2004.10.004","volume":"35","author":"ES Trombetta","year":"2005","unstructured":"Trombetta ES, Parodi AJ: Glycoprotein reglucosylation. Methods. 2005, 35: 328-337. 10.1016\/j.ymeth.2004.10.004","journal-title":"Methods"},{"key":"730_CR35","first-page":"6282","volume":"63","author":"K Noda","year":"2003","unstructured":"Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, Kitada T, Honke K, Suzuki K, Yoshihara H, Yoshikawa K: Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res. 2003, 63: 6282-6289.","journal-title":"Cancer Res"},{"key":"730_CR36","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.1073\/pnas.0507375102","volume":"102","author":"X Wang","year":"2005","unstructured":"Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M: Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA. 2005, 102: 15791-15796. 10.1073\/pnas.0507375102","journal-title":"Proc Natl Acad Sci USA"},{"key":"730_CR37","first-page":"2237","volume":"59","author":"E Miyoshi","year":"1999","unstructured":"Miyoshi E, Noda K, Ko JH, Ekuni A, Kitada T, Uozumi N, Ikeda Y, Matsuura N, Sasaki Y, Hayashi N: Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res. 1999, 59: 2237-2243.","journal-title":"Cancer Res"},{"key":"730_CR38","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1074\/jbc.M510893200","volume":"281","author":"X Wang","year":"2006","unstructured":"Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N: Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem. 2006, 281: 2572-2577. 10.1074\/jbc.M510893200","journal-title":"J Biol Chem"},{"key":"730_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0168-8278(95)80269-X","volume":"22","author":"PJ Scheuer","year":"1995","unstructured":"Scheuer PJ: The nomenclature of chronic hepatitis: time for a change. J Hepatol. 1995, 22: 112-114. 10.1016\/0168-8278(95)80269-X","journal-title":"J Hepatol"},{"key":"730_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991, 13: 372-374. 10.1016\/0168-8278(91)90084-O","journal-title":"J Hepatol"},{"key":"730_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10522-008-9140-z","volume":"9","author":"V Vanhooren","year":"2008","unstructured":"Vanhooren V, Laroy W, Libert C, Chen C: N-Glycan profiling in the study of human aging. Biogerontology. 2008, 9: 351-356. 10.1007\/s10522-008-9140-z","journal-title":"Biogerontology"},{"key":"730_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0076-6879(94)30010-0","volume":"230","author":"A Dell","year":"1994","unstructured":"Dell A, Reason AJ, Khoo KH, Panico M, McDowell RA, Morris HR: Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol. 1994, 230: 108-132. full_text","journal-title":"Methods Enzymol"},{"key":"730_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0076-6879(06)15005-3","volume":"415","author":"J Jang-Lee","year":"2006","unstructured":"Jang-Lee J, North SJ, Sutton-Smith M, Goldberg D, Panico M, Morris H, Haslam S, Dell A: Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies. Methods Enzymol. 2006, 415: 59-86. 10.1016\/S0076-6879(06)15005-3","journal-title":"Methods Enzymol"},{"key":"730_CR44","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1021\/pr7008252","volume":"7","author":"A Ceroni","year":"2008","unstructured":"Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM: GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res. 2008, 7: 1650-1659. 10.1021\/pr7008252","journal-title":"J Proteome Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-9-215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:12:05Z","timestamp":1630473125000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-9-215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-9-215","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]},"assertion":[{"value":"9 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"215"}}